Literature DB >> 9652673

Alternative hypothesis for efficacy of macrolides in acute coronary syndromes.

D Martin, J Bursill, M R Qui, S N Breit, T Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9652673     DOI： 10.1016/S0140-6736(05)78804-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

Review 2.  Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?

Authors:  J L Mehta; F Romeo
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

3.  Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.

Authors:  Christian M Jespersen; Bodil Als-Nielsen; Morten Damgaard; Jørgen Fischer Hansen; Stig Hansen; Olav H Helø; Per Hildebrandt; Jørgen Hilden; Gorm B Jensen; Jens Kastrup; Hans Jørn Kolmos; Erik Kjøller; Inga Lind; Henrik Nielsen; Lars Petersen; Christian Gluud
Journal:  BMJ       Date:  2005-12-08

4.  No causal association between inflammation and Chlamydia pneumoniae in patients with chronic ischemic arterial disease.

Authors:  Raúl Altman; Jorge Rouvier; Alejandra Scazziota; Claudio Gonzalez
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

5.  Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease.

Authors:  Christian Gluud; Bodil Als-Nielsen; Morten Damgaard; Jørgen Fischer Hansen; Stig Hansen; Olav H Helø; Per Hildebrandt; Jørgen Hilden; Gorm Boje Jensen; Jens Kastrup; Hans Jørn Kolmos; Erik Kjøller; Inga Lind; Henrik Nielsen; Lars Petersen; Christian M Jespersen
Journal:  Cardiology       Date:  2008-05-02       Impact factor: 1.869

6.  Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline.

Authors:  L A Jackson; N L Smith; S R Heckbert; J T Grayston; D S Siscovick; B M Psaty
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

7.  Risk factors in coronary atherosclerosis athero-inflammation: the meeting point.

Authors:  Raul Altman
Journal:  Thromb J       Date:  2003-07-17

Review 8.  Atherosclerosis: process, indicators, risk factors and new hopes.

Authors:  Mahmoud Rafieian-Kopaei; Mahbubeh Setorki; Monir Doudi; Azar Baradaran; Hamid Nasri
Journal:  Int J Prev Med       Date:  2014-08

9.  Clarithromycin-induced Coronary Vasospasms Caused Acute Coronary Syndrome in a 19-year-old Male Patient.

Authors:  Masahiro Ishikura; Akihiro Endo; Takahiro Sakamoto; Junya Tanabe; Koichi Okazaki; Takeshi Ouchi; Nobuhide Watanabe; Kazuaki Tanabe
Journal:  Intern Med       Date:  2020-09-19       Impact factor: 1.271
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.